Multicenter study of Matrix Metalloproteinase (MMP)-9 expression on meibomian gland dysfunction using dry eye diagnostic device "InflammaDry"
Phase 1
- Conditions
- Meibomian gland dysfunction
- Registration Number
- JPRN-UMIN000017117
- Lead Sponsor
- id and Meibomian Gland Working Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who may have the possibility of contagious diseases
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MMP-9 positive expression on InflammaDry in patients with meibomian gland dysfunction
- Secondary Outcome Measures
Name Time Method Slit-lamp findings, meibo-score, Schirmer test, tear break-up time